San Donato Hospital
Leukemia treatment cost in Italy typically depends on the diagnostic approach and therapy type, with a Bone marrow biopsy running from $500 to $1,300. Primary treatments like Leukemia chemotherapy often range from $30,000 to $55,000, while advanced CAR T-cell therapy costs from $350,000 to $500,000. Expenses vary based on disease stage and hospital stay duration, typically offering 20-40% savings compared to the US. Top treatment centers are located in Milan.
Typical Leukemia Treatment Costs in Italy
Bookimed Expert Insight: Patients with complex hematological conditions benefit from integrated research and clinical care at IRCCS-accredited centers. Professor Fabio Ciceri at San Raffaele specializes in advanced cell and gene therapy clinical trials for leukemia. This center is ideal for patients seeking the world's first stem cell therapies or bone marrow transplantation. The facility manages over 52,000 operations annually, providing high-volume expertise for high-risk cases.
| Italy | Turkey | Austria | |
| Chemotherapy for breast cancer | from $4,500 | from $1,200 | from $15,000 |
| CAR T-cell therapy | from $350,000 | from $150,000 | from $350,000 |
| Leukemia chemotherapy | from $30,000 | from $8,000 | from $15,000 |
| Therapeutic Apheresis | from $2,200 | from $1,350 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Leukemia treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Leukemia treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Leukemia treatment journey.
Prof. Fabio Ciceri leads the Hematology and Bone Marrow Transplantation Unit at San Raffaele – a pioneer in cell and gene therapy trials for leukemia.
Written by Anna Leonova
Italy hosts globally recognized leukemia centers like San Raffaele Research Hospital in Milan. These facilities hold IRCCS accreditation from the Italian Ministry of Health. They integrate high-volume clinical care with advanced hematology research to provide innovative stem cell therapies and CAR T-cell treatments.
Bookimed Expert Insight: San Raffaele stands out because it operates one of Europe's largest research hospitals. They performed the world’s first stem cell therapy for rare immune disorders. Our data shows it serves 300,000 patients yearly. This massive volume ensures doctors like Dr. Fabio Ciceri maintain unmatched expertise in complex blood disorders.
Patient Consensus: Patients emphasize that northern centers like San Raffaele offer the easiest access to experimental trials. One patient noted that getting a second opinion at these top clinics helped correct a previous misdiagnosis of leukemia.
Italy offers advanced hematology treatments including CAR T-cell therapy and specialized stem cell transplants. Research centers like San Raffaele utilize gene therapy and molecular diagnostics. Highly trained specialists treat complex leukemia cases within JCI or IRCCS-accredited research hospitals in Milan and Pavia.
Bookimed Expert Insight: Italian research hospitals serve over 300,000 patients yearly while maintaining IRCCS status. This designation confirms they combine direct clinical care with active research. Dr. Fabio Ciceri at San Raffaele has published over 180 papers on hematological cancers. This deep academic focus often grants patients earlier access to experimental protocols.
Patient Consensus: Patients note that CAR-T therapy has led to long-term remission when chemotherapy failed. Many emphasize that getting specialized second opinions in Milan can quickly clarify initial diagnosis errors.
Italy hosts globally recognized leukemia specialists within IRCCS-accredited research hospitals. These experts lead advancements in allogeneic transplants and gene therapies. Top hematologists practice in Milan and Rome. They hold prestigious leadership roles in European oncology networks and clinical trial groups.
Bookimed Expert Insight: Data shows that San Raffaele performs over 52,000 operations annually and holds a unique IRCCS status. This designation means the clinic must combine patient care with active research. For leukemia patients, this provides direct access to the world’s first licensed stem cell therapies not found in standard hospitals.
Patient Consensus: Patients note that top Italian specialists often resolve complex misdiagnoses through advanced blood analysis. They emphasize traveling directly to high-volume centers in Milan for the highest level of competence.
During your first leukemia appointment in Italy, ask about personalized protocols like European LeukemiaNet guidelines and CAR T-cell therapy eligibility. Clarify timelines for bone marrow biopsies and specialized diagnostic tests. Confirm how doctors manage side effects and infections within the IRCCS-accredited research hospital framework.
Bookimed Expert Insight: Italian IRCCS-accredited centers like San Raffaele combine clinical care with high-level research. These institutions perform over 52,000 operations annually and offer unique therapies, such as the world's first ADA-SCID stem cell treatment. If you are seeking advanced cell or gene therapy, prioritize hospitals with this dual research-clinical designation for the best access to experimental protocols.
Patient Consensus: Patients note that some initial consultations can feel brief, so it is vital to bring a translated list of questions and request a written summary. Many recommend confirming if the hospital provides interpreters or if a private one is needed for complex medical discussions.